ACADIA Pharmaceuticals
ACAD
#3605
Rank
A$5.12 B
Marketcap
A$30.04
Share price
-3.19%
Change (1 day)
13.34%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): A$0.43 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.04 Billion. In 2024 the company made an earning of A$0.36 Billion, an increase over its 2023 earnings that were of -A$72.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.43 B18.55%
2024 A$0.36 B-605.67%
2023 -A$72.08 Million-76.09%
2022 -A$0.31 Billion27.41%
2021 -A$0.24 Billion-40.38%
2020 -A$0.4 Billion19.88%
2019 -A$0.34 Billion-3.92%
2018 -A$0.35 Billion-15.04%
2017 -A$0.41 Billion6.33%
2016 -A$0.39 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$53.6 Million81.93%
2012 -A$29.46 Million-8.73%
2011 -A$32.28 Million-251.39%
2010 A$21.31 M-133.2%
2009 -A$64.22 Million-30.82%
2008 -A$92.82 Million6.43%
2007 -A$87.22 Million25.89%
2006 -A$69.28 Million36.99%
2005 -A$50.57 Million37.22%
2004 -A$36.86 Million19.96%
2003 -A$30.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.74 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.73 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.77 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.34 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.18 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$54.56 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA